BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16868132)

  • 41. Orbit and orbital apex.
    Robinson D; Wilcsek G; Sacks R
    Otolaryngol Clin North Am; 2011 Aug; 44(4):903-22, viii. PubMed ID: 21819879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgical treatment of Graves' ophthalmopathy.
    Eckstein A; Schittkowski M; Esser J
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):339-58. PubMed ID: 22632370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III).
    Schuh A; Ayvaz G; Baldeschi L; Baretić M; Bechtold D; Boschi A; Brix TH; Burlacu MC; Ciric J; Covelli D; Currò N; Donati S; Eckstein AK; Fichter N; Führer D; Horn M; Jabłońska-Pawlak A; Juri Mandić J; Kahaly GJ; Konuk O; Langbein A; Lanzolla G; Marcocci C; Marinò M; Miśkiewicz P; Beleslin BN; Pérez-Lázaro A; Pérez-López M; Ponto KA; Quinn A; Rudofsky G; Salvi M; Schittkowski MP; Tanda ML; Toruner F; Vaidya B; Hintschich CR
    Br J Ophthalmol; 2024 Jan; 108(2):294-300. PubMed ID: 36627174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proptosis reduction by clinical vs radiological modalities and medial vs inferomedial approaches: comparison following endoscopic transnasal orbital decompression in patients with dysthyroid orbitopathy.
    Thapa S; Gupta AK; Gupta A; Gupta V; Dutta P; Virk RS
    JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):329-34. PubMed ID: 25654307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
    Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
    Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial.
    Moleti M; Violi MA; Montanini D; Trombetta C; Di Bella B; Sturniolo G; Presti S; Alibrandi A; Campennì A; Baldari S; Trimarchi F; Vermiglio F
    J Clin Endocrinol Metab; 2014 May; 99(5):1783-9. PubMed ID: 24432992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional and esthetic outcome after bony lateral wall decompression with orbital rim removal and additional fat resection in graves' orbitopathy with regard to the configuration of the lateral canthal region.
    Fichter N; Krentz H; Guthoff RF
    Orbit; 2013 Aug; 32(4):239-46. PubMed ID: 23808640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Endoscopic trans-ethmoid medial orbital wall decompression combined with intraconal fat decompression for Graves' ophthalmopathy].
    Wu WC; Yu B; Wang ML; Huang L; Tu YH; Chen B; Qu J; Wang QM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):807-13. PubMed ID: 22321417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment options for Graves' orbitopathy.
    Marcocci C; Altea MA; Leo M
    Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intraorbital pressure measured before, during, and after surgical decompression in Graves' orbitopathy].
    Berthout A; Vignal C; Jacomet PV; Galatoire O; Morax S
    J Fr Ophtalmol; 2010 Nov; 33(9):623-9. PubMed ID: 21047700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Four perspectives on Graves' orbitopathy - from the point of view of the patient, general practitioner, endocrinologist, and ophthalmologist].
    Filipsson Nyström H; Fellbrant K; Lundberg C; Botusan I; Åsman P; Träisk F
    Lakartidningen; 2024 May; 121():. PubMed ID: 38775447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of patient with Gaves' orbitopathy].
    Di Fiore A; Paone L; Rendina R; D'Armiento E; Coccaro C; Alessandrini S; Marenco M; Ulisse S
    Clin Ter; 2012 Nov; 163(6):e463-74. PubMed ID: 23306763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Orbital decompression for Graves' orbitopathy in England.
    Perros P; Chandler T; Dayan CM; Dickinson AJ; Foley P; Hickey J; Macewen CJ; Lazarus JH; McLaren J; Rose GE; Uddin JM; Vaidya B
    Eye (Lond); 2012 Mar; 26(3):434-7. PubMed ID: 22157920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Graves' Orbitopathy: Current Concepts for Medical Treatment.
    Oeverhaus M; Stöhr M; Möller L; Führer D; Eckstein A
    Klin Monbl Augenheilkd; 2021 Jan; 238(1):24-32. PubMed ID: 33506447
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical decompression in endocrine orbitopathy. Visual evoked potential evaluation and effect on the optic nerve.
    Clauser LC; Tieghi R; Galie' M; Franco F; Carinci F
    J Craniomaxillofac Surg; 2012 Oct; 40(7):621-5. PubMed ID: 22424910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
    Bartalena L; Baldeschi L; Dickinson AJ; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits MP; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas G; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM
    Thyroid; 2008 Mar; 18(3):333-46. PubMed ID: 18341379
    [No Abstract]   [Full Text] [Related]  

  • 57. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pediatric thyroid-associated orbitopathy: the Children's Hospital of Philadelphia experience and literature review.
    Goldstein SM; Katowitz WR; Moshang T; Katowitz JA
    Thyroid; 2008 Sep; 18(9):997-9. PubMed ID: 18713025
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
    Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
    Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of Graves' orbitopathy (DiaGO): results of a pilot study to assess the utility of an office tool for practicing endocrinologists.
    Mitchell AL; Goss L; Mathiopoulou L; Morris M; Vaidya B; Dickinson AJ; Quinn A; Dayan C; McLaren J; Hickey JL; Lazarus JH; Rose GE; Foley P; MacEwen CJ; Perros P
    J Clin Endocrinol Metab; 2015 Mar; 100(3):E458-62. PubMed ID: 25485725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.